Name: Compounded Zepbound — Tirzepatide From $399/mo
Brand: SlimVault
Availability: InStock

About This Medication

WHAT IS ZEPBOUND?

Zepbound is the weight-management branded version of tirzepatide, FDA-approved in November 2023 for chronic weight management in adults with obesity or overweight with a weight-related condition. It was also approved in December 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity — making it the first medication ever approved for sleep apnea treatment.

Zepbound and Mounjaro contain the exact same active ingredient at the same doses. The difference is the indication: Mounjaro is labeled for type 2 diabetes, Zepbound for weight management and sleep apnea. In clinical practice, this distinction affects insurance coverage but not pharmacological effect.

In the SURMOUNT-1 trial, participants on 15mg tirzepatide (the same molecule) lost an average of 22.5% of body weight over 72 weeks. Approximately 60% of patients at 10–15mg lost 20% or more of their total body weight — a result unmatched by any other FDA-approved medication.

22.5%

Average body weight loss at 15mg in SURMOUNT-1 over 72 weeks

Indications: weight management AND obstructive sleep apnea

10mg

Minimum maintenance dose required for sleep apnea indication

60%

Of patients at 10–15mg lost 20%+ of body weight

Dosing Protocol

TITRATION SCHEDULE

Phase	Timing	Dose	What to Expect
Initiation	Weeks 1–4	2.5mg	Tolerability dose. Not therapeutic. GI side effects most common here. Eat bland, small meals around injection day.
Step 2	Weeks 5–8	5mg	First maintenance-eligible dose. 16% average weight loss at this level in 72-week trials. Many patients stay here.
Step 3	Weeks 9–12	7.5mg	Bridge step toward 10mg. Not a standard maintenance dose. Significant appetite reduction at this level.
Maintenance	Week 13+	10mg	Primary maintenance for weight loss AND minimum dose for sleep apnea indication. 21.4% average weight loss.
Step 5	Week 17+	12.5mg	Escalation step toward maximum. Use only if 10mg tolerated and more weight loss is needed.
Maximum	Week 21+	15mg	Maximum approved dose. 22.5% average weight loss. 60% of patients lost 20%+ over 72 weeks.

Safety Information

SIDE EFFECTS

Common Side Effects Usually improve over time

Nausea (17–22%) — worst at dose initiation and increases. Eating low-fat, small meals significantly helps.
Diarrhea (13–16%) — typically resolves within 4–8 weeks at a stable dose.
Vomiting (6–10%) — contact your provider if vomiting prevents you from staying hydrated.
Decreased appetite — the therapeutic goal for weight management.
Constipation — alternates with diarrhea in early weeks for many patients.
Headache — particularly in the first 2–4 weeks of treatment.
Fatigue — on and around injection day during early titration.

Serious Side Effects Seek care immediately

Thyroid C-cell tumors — FDA boxed warning. Contraindicated in patients with personal or family history of MTC or MEN 2.
Pancreatitis — severe upper abdominal pain radiating to the back. Stop medication immediately and seek emergency care.
Acute kidney injury — primarily from dehydration secondary to GI side effects. Maintain adequate hydration.
Gallbladder problems — gallstones and cholecystitis reported. Symptoms include right-sided abdominal pain and fever.
Hypoglycemia — elevated risk when combined with insulin or sulfonylurea medications.
Anaphylaxis — rare serious allergic reaction requiring immediate emergency treatment.

Customer Experiences

REVIEWS

4.9

★★★★★

Verified purchases

★★★★★

"Down 33 pounds in 4 months on Zepbound. I started it for weight loss but my sleep apnea symptoms have also improved dramatically — I am sleeping through the night for the first time in years. Two benefits for one medication."

Jennifer A.

Zepbound 10mg · 4 Months

★★★★★

"I tried Wegovy and got disappointing results. Zepbound at 15mg is a completely different experience. My appetite is essentially gone. I eat when I know I need to rather than when I want to. Down 47 lbs in 6 months."

Nicole P.

Zepbound 15mg · 6 Months

★★★★★

"Shipping was discreet, medication arrived cold, and the results speak for themselves. Lost 16 lbs in 8 weeks at 7.5mg. The dose cards on this site made it so easy to understand where I am in the titration."

Sarah W.

Zepbound 7.5mg · 2 Months

Questions Answered

ZEPBOUND FAQ

How does Zepbound differ from Mounjaro? +

Zepbound and Mounjaro are the same molecule (tirzepatide) at the same doses. The difference is the FDA-approved indication: Mounjaro is labeled for type 2 diabetes, Zepbound for weight management and sleep apnea. The titration schedule, dose options, and clinical effects are identical. Insurance coverage may differ based on your diagnosis.

Is Zepbound approved for sleep apnea? +

Yes. Zepbound received FDA approval in December 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity — the first medication ever approved for this condition. The minimum maintenance dose for the sleep apnea indication is 10mg weekly.

How much weight can I expect to lose? +

Clinical trial data shows 16% average weight loss at 5mg, 21.4% at 10mg, and 22.5% at 15mg over 72 weeks. Approximately 60% of patients at 10–15mg lost 20% or more of their starting body weight. Individual results vary significantly based on diet, activity level, and metabolic factors.

What if I experience bad side effects at a higher dose? +

It is perfectly acceptable — and clinically recommended — to step back to a lower dose if side effects at a higher dose are intolerable. Staying at a lower maintenance dose long-term is a valid approach. Many patients who cannot tolerate 15mg achieve excellent results at 10mg permanently.

Related Medications

Zepbound

WHAT IS ZEPBOUND?

TITRATION SCHEDULE

SIDE EFFECTS

REVIEWS

ZEPBOUND FAQ

YOU MAY ALSO CONSIDER